At day 28, patients in both groups demonstrated a significant improvement in sleep habits from baseline. EpiCeram patients had a 74% reduction in the measure of difficulty sleeping (from 3.5 to 0.9, p<0.0001).
EpiCeram Greatly Impoved sleep habits
in Patients with Paediatric Atopic Dermatitis

(Adapted from Data on File1)
1. Sugarman et al. J. of Drugs in Derm. 12, 1106-1111, 2009